Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Breast Cancer Screening Using DNA Methylation Changes in Circulated Tumor, PBMC and T-cells DNA.

NCT03480659 is registered in ClinicalTrials.gov with HKGepitherapeutics as lead sponsor.

NCT NCT03480659
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03480659 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Breast Cancer Screening Using DNA Methylation Changes in Circulated Tumor, PBMC and T-cells DNA.
Lead sponsor
HKGepitherapeutics
Phase
Observational
Overall status
Terminated
Start date
June 1, 2018
Completion date
September 1, 2021
Enrollment
165 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, breast cancer female